DOSTARLIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

DOSTARLIMAB

Official Name

English

TSR-042

Code

English

GSK-4057190

Code

English

dostarlimab [INN]

Common Name

English

GSK4057190

Code

English

IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1 (PDCD1)) (HUMANIZED CLONE ABT1 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONE ABT1 .KAPPA.-CHAIN, DIMER

Systematic Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN PROGRAMMED CELL DEATH PROPTEIN 1 (PROTEIN PD-1, CD279 ANTIGEN))HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-440) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*01 (92%) (IGHD)-IGHJ6*01 (93%)) (8.8.6) (1-113) -HOMO SAP

Systematic Name

English

Dostarlimab [WHO-DD]

Common Name

English

DOSTARLIMAB [USAN]

Common Name

English

WBP-285

Code

English

Code System Code Type Description

RXCUI

2539967

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

NCI_THESAURUS

C126799

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

USAN

EF-55

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

FDA UNII

P0GVQ9A4S5

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

INN

10787

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

WIKIPEDIA

Dostarlimab

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

SMS_ID

100000181573

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

DAILYMED

P0GVQ9A4S5

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

DRUG BANK

DB15627

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

CAS

2022215-59-2

Created by admin on Sat Dec 16 10:21:31 GMT 2023 , Edited by admin on Sat Dec 16 10:21:31 GMT 2023

PRIMARY

ACTIVE MOIETY


					P0GVQ9A4S5